ocrevus zunovo
(ocrelizumab and hyaluronidase)Genentech, Inc.
Usage: OCREVUS ZUNOVO is indicated for treating relapsing forms of multiple sclerosis (MS), including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, as well as primary progressive MS, in adults.